Back

Energetic and myocellular pathways in cardiac and skeletal muscle following anthracycline chemotherapy

28 August 2022 (12:45 - 12:55)
Organised by:
Congress Presentation Part of: Heart failure characterisation with echocardiography Morphology, Dimensions, Volumes and Mass ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor David Gamble

University of Aberdeen, Aberdeen (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Right ventricular adaptation and subclinical damage by echocardiography in heart transplantation recipients: insights from myocardial work index
Professor L. Sade (Pittsburgh, US)
Abstract Slides Video
Presentation thumbnail
The importance of patient characteristics, operators, and image quality for accurate diagnoses of heart failure by general practitioners using hand-held ultrasound
Mrs M. Magelssen (Trondheim, NO)
Abstract Slides Video
Presentation thumbnail
Trajectory of pulmonary congestion by lung ultrasound in patients with acute myocardial infarction and association with cardiac structure and function
Associate Professor E. Platz (Boston, US)
Abstract Slides Video
Presentation thumbnail
Prognostic power of a new index of right ventricle-pulmonary artery coupling based on right ventricular volumes in patients with secondary tricuspid regurgitation
Doctor A. Cascella (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Prognostic value of left and right ventricular strain in heart failure with reduced and preserved ejection fraction: a meta-analysis
Abstract Slides

Access the full session

Session thumbnail
Heart failure characterisation with echocardiography

The Event

Event poster

ESC Congress 2022

28 August 2022 12:45 CET
You may be interested in
thumbnail
Congress Presentation
Imaging of cancer treatment-related cardiovascular toxicity
thumbnail
Congress Session
Cardiotoxicity of cancer therapies
thumbnail
Congress Presentation
Cardiac rehabilitation in heart failure patients undergoing cancer treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources